TY - JOUR
T1 - Comparison of panel-reactive antibody levels in caucasian and african american renal transplant candidates
AU - Cooper, Todd Y.
AU - Jordan, Curt L.
AU - Willimon, Carla M.
AU - Land, Geoffrey A.
PY - 1995/8/27
Y1 - 1995/8/27
N2 - PRA levels from 58 Caucasian and 70 African American ESRD patients were compared against a panel of cryopreserved lymphocytes from 60 donors (40 Caucasian, 15 African American, 5 others) to determine whether there was significant racial influence on PRA outcome. African Americans were found to have significantly higher mean PRA levels than Caucasians (27% vs. 18%, P=0.02). Restricting this analysis to only 1° transplant candidates showed predictably lower mean PRAs: 6% in Caucasians and 15% in African Americans, but the difference between the two groups remained significant (P=0.015). The percentage of patients with PRA≥10% was also greater among African Americans than Caucasians (43% vs. 24%, P=0.026). For patients not previously transplanted, the difference between these frequencies remained significant: 11% in Caucasians, 30% in African Americans (P=0.025). Untransplanted African American patients with positive PRAs (≥10%) had significantly higher PRA against African American cell donors (mean = 55%) than against Caucasian cell donors (mean = 44%) (mean difference = 10.6%, P=0.0056). African Americans were more frequently transfused than Caucasians. The percentage of patients not previously transplanted receiving 0, 1-5, and >5 transfusions were 69%, 22%, and 9% for Caucasians and 43%, 44%, and 13% for African Americans (P=0.03). This higher transfusion rate is the most likely contributor to the elevated PRA levels observed in African Americans.
AB - PRA levels from 58 Caucasian and 70 African American ESRD patients were compared against a panel of cryopreserved lymphocytes from 60 donors (40 Caucasian, 15 African American, 5 others) to determine whether there was significant racial influence on PRA outcome. African Americans were found to have significantly higher mean PRA levels than Caucasians (27% vs. 18%, P=0.02). Restricting this analysis to only 1° transplant candidates showed predictably lower mean PRAs: 6% in Caucasians and 15% in African Americans, but the difference between the two groups remained significant (P=0.015). The percentage of patients with PRA≥10% was also greater among African Americans than Caucasians (43% vs. 24%, P=0.026). For patients not previously transplanted, the difference between these frequencies remained significant: 11% in Caucasians, 30% in African Americans (P=0.025). Untransplanted African American patients with positive PRAs (≥10%) had significantly higher PRA against African American cell donors (mean = 55%) than against Caucasian cell donors (mean = 44%) (mean difference = 10.6%, P=0.0056). African Americans were more frequently transfused than Caucasians. The percentage of patients not previously transplanted receiving 0, 1-5, and >5 transfusions were 69%, 22%, and 9% for Caucasians and 43%, 44%, and 13% for African Americans (P=0.03). This higher transfusion rate is the most likely contributor to the elevated PRA levels observed in African Americans.
UR - http://www.scopus.com/inward/record.url?scp=0029119089&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029119089&partnerID=8YFLogxK
U2 - 10.1097/00007890-199508270-00004
DO - 10.1097/00007890-199508270-00004
M3 - Article
C2 - 7652759
AN - SCOPUS:0029119089
SN - 0041-1337
VL - 60
SP - 327
EP - 330
JO - Transplantation
JF - Transplantation
IS - 4
ER -